Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Xiuwei Yang, PhD

Why are there no ratings?
  • About

    Faculty Rank

    Assistant Professor
Are you happy with the care you received from this provider?

Please let us know by filling out a patient satisfaction survey when you get one. You can also leave an online review by clicking the button below.

Leave a review
  • Research

    Cancer Center Member

    Research Focus

    The primary research interest of our laboratory is to understand how cell adhesion molecules or receptors contribute to cancer development, progression and metastasis, and to evaluate the potential of these molecules as candidate biomarkers or therapeutic targets for the early detection, diagnosis and treatment of such malignant diseases. Our recent projects involve the functional analyses of heterodimeric adhesion receptors, named laminin-binding (LB) integrins (i.e., alpha3/beta1, alpha6/beta1 and alpha6beta4, and their associated tetraspanin CD151, in human breast, ovarian and skin cancer as well as mammary gland development. In these studies, we have attempted to assess tumor onset and metastasis as well as underlying mechanisms by using gene-targeted mice, transgenic animal models and 3D cell culture model. Our current studies focus on the following functional aspects of these molecules and their associated protein complexes:

    • Signaling roles in tumor cell proliferation, motility and invasion in multiple types of human carcinomas.
    • Genetic and transcriptional regulation of the niches and homeostasis of normal or malignant epithelial stem/progenitor cells.
    • Control of the reciprocal interactions between tumor cells and their microenvironments (e.g., remodeling of extracellular matrices and infiltration of stroma cells).
    • Transcriptional regulation of cell-cell contacts and Epithelial-Mesenchymal Transition (EMT) during tumor progression.
    • Molecular contribution to late-stage tumor metastasis, e.g., tumor cell extravasation through vasculature or colonization at distant sites.
    • Collaboration with diverse oncogenic or pro-malignant pathways, including those driven by Receptor Tyrosine Kinases (e.g., EGFR and ErbB2), focal adhesion kinase (FAK) and small GTPases (Rac1, Rho A and Cdc42), as well as canonical Wnt signaling.

    Programs

    • Cancer Cell Biology and Signaling

    College & Department

    • College of Medicine
    • Department of Pharmacology and Nutritional Sciences

    For Referring Physicians

    MN-352
    Lexington, KY 40536
    United States

    Phone
    859-323-1996